There are many reasons it's important to know what blood type you are, and you never know when you may need to know.

The protective proteins in our bodies aren’t just great for fending off infection—they could also fight the effects of ...

Scientists from RMIT University and the Doherty Institute have developed a new blood test that could screen cancer patients ...

Two clinical trials testing the antibody loncastuximab tesirine (Zynlonta) showed encouraging results in patients with high-risk forms of two blood cancers ... options also show high efficacy ...

contributed structural insights that helped an international team of investigators show that two newly isolated broadly inhibitory antibodies can target a key part of the protein that malarial ...

Two clinical trials testing the antibody loncastuximab tesirine (Zynlonta) showed encouraging results in patients with high-risk forms of two blood cancers ... options also show high efficacy ...

Researchers at Uppsala University and KTH Royal Institute of Technology have created an antibody that has the potential to ...

Presentation: Two clinical trials testing the antibody loncastuximab tesirine (Zynlonta) showed encouraging results in patients with high-risk forms of two blood cancers – follicular lymphoma and ...